Medication Adherence With Diabetes Medication: A Systematic Review of the Literature

The Diabetes Educator

Volumn 42, Issue 1, 2016, Pages 34-71

  Capoccia, Kam ^a   Odegard, Peggy S ^b   Letassy, Nancy ^c  

^a WESTERN NEW ENGLAND UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

COST OF ILLNESS; DIABETES MELLITUS; ECONOMICS; HEALTH CARE COST; HUMAN; MEDICATION COMPLIANCE; PSYCHOLOGY; RISK FACTOR;

COST OF ILLNESS; DIABETES MELLITUS; HEALTH CARE COSTS; HUMANS; HYPOGLYCEMIC AGENTS; MEDICATION ADHERENCE; RISK FACTORS;

EID: 84954461761     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721715619038     Document Type: Article

References (103)

1. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007;33(6):1014-1029.
2. Moher D, Liberati A, Tezlaff J, Altman DG, The PRISMA Group (2009). Prefered Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Open Med. 2009;3(3):123-130.
3. Morisky DE, Green W, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
4. Toobert DJ, Hampson SE, Glasgow RE. The summary of a diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943-950.
5. Mechanick JI, Camacho PM, Cobin RH et al. American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines—2010 update. Endocr Pract. 2010;16(2):270-283.
6. Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care. 2010;48(5):409-417.
7. Gu Q, Zeng F, Patel BV, Tripoli LC. Part D coverage gap and adherence to diabetes medications. Am J Manag Care. 2010;16(12):911-918.
8. Stuart B, Simoni-Wastila L, Yin X, Davidoff A, Zuckerman IH, Doshi J. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans. Med Care. 2011;49(5):511-515.
9. Colombi AM, Yu-Isenberg K, Priest J. The effects of health plan copayments on adherence to oral diabetes medication and health resource utilization. J Occup Environ Med. 2008;50(5):535-541.
10. Gibson TB, Song X, Alemayehu B et al. Cost sharing, adherence, and health outcomes in patients with diabetes. Am J Manag Care. 2010;16(8):589-600.
11. Zeng F, An JJ, Scully R, Barrington C, Patel BV, Nichol MB. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation. Value Health. 2010;13(6):846-852.
12. Maciejewski ML, Bryson CL, Perkins M et al. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Am J Manag Care. 2010;16(1):e20-e34.
13. Sharma KP, Taylor TN. Pharmacy effect on adherence to antidiabetic medications. Med Care. 2012;50(8):685-691.
14. Zhang L, Zakharyan A, Stockl KM, Harada AS, Curtis BS, Solow BK. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes. J Med Econ. 2011;14(5):562-567.
15. Yang Y, Thumula V, Pace PF, Banahan BF III, Wilkin NE, Lobb WB. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Clin Ther. 2009;31(10):2178-2188.
16. Kreyenbuhl J, Dixon LB, McCarthy JF, Soliman S, Ignacio RV, Valenstein M. Does adherence to medications for type 2 diabetes differ between individuals with vs. without schizophrenia? Schizophr Bull. 2010;36(2):428-435.
17. Trinacty CM, Adams AS, Soumerai SB et al. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res. 2009;9:24.
18. Adams AS, Trinacty CM, Zhang F et al. Medication adherence and racial differences in A1c control. Diabetes Care. 2008;31(5):916-921.
19. Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther. 2007;29(6 pt 1):1294-1305.
20. Nair KV, Miller K, Park J, Allen RR, Saseen JJ, Biddle V. Prescription co-pay reduction program for diabetic employees. Popul Health Manag. 2010;13(5):235-245.
21. Kleinman NL, Schaneman JL, Lynch WD. The association of insulin medication possession ratio, use of insulin glargine, and health benefit costs in employees and spouses with type 2 diabetes. J Occup Environ Med. 2008;50(12):1386-1393.
22. Donnelly LA, Morris AD, Evans JM; DARTS/MEMO collaboration. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM. 2007;100(6):345-350.
23. Kindmalm L, Melander A, Nilsson JL. Refill adherence of antihyperglycaemic drugs related to glucose control (HbA1C) in patients with type 2 diabetes. Acta Diabetol. 2007;44(4):209-213.
24. Penning-van Beest FJ, van der Bij S, Erkens JA, Kessabi S, Groot M, Herings RM, Effect of non-persistent use of oral glucose-lowering drugs on HbA1C goal attainment. Curr Med Res Opin. 2008;24(9):2523-2529.
25. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care. 2008;14(2):71-75.
26. Lafata JE, Dobie EA, Divine GW, Ulcickas Yood ME, McCarthy BD. Sustained hyperglycemia among patients with diabetes: what matters when action is needed? Diabetes Care. 2009;32(8):1447-1452.
27. Yu AP, Yu YF, Nichol MB. Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes—an application of marginal structural models. Value Health. 2010;13(8):1038-1045.
28. Bryson CL, Au DH, Maciejewski ML et al. Wide clinic-level variation in adherence to oral diabetes medications in the VA. J Gen Intern Med. 2013;28(5):698-705.
29. Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, Stolk RP, Denig P; Groningen Initiative to Analyze Type 2 Diabetes Treatment Group. Medication adherence affects treatment modifications in patients with type 2 diabetes. Clin Ther. 2011;33(1):121-134.
30. Stuart BC, Simoni-Wastila L, Zhao L, Lloyd JT, Doshi JA. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 2009;32(4):647-649.
31. Cheong C, Barner JC, Lawson KA, Johnsrud MT. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Clin Ther. 2008;30(10):1893-1907.
32. Fabunmi R, Nielsen LL, Quimbo R et al. Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine. Curr Med Res Opin. 2009;25(3):777-786.
33. Shah NR, Hirsch AG, Zacker C, Taylor S, Wood GC, Stewart WF. Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med. 2009;24(2):233-237.
34. Devine S, Vlahiotis A, Sundar H. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy. J Med Econ. 2010;13(2):203-211.
35. O'Shea MP, Teeling M, Bennett K. An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents. Pharmacoepidemiol Drug Saf. 2013;22(12):1336-1344.
36. Raebel MA, Carroll NM, Ellis JL, Schroeder EB, Bayliss EA. Importance of including early nonadherence in estimations of medication adherence. Ann Pharmacother. 2011;45(9):1053-1060.
37. Fallis BA, Dhalla IA, Klemensberg J, Bell CM. Primary medication non-adherence after discharge from a general internal medicine service. PLoS One. 2013;8(5):e61735.
38. Lim PC, Lim K. Evaluation of a pharmacist-managed diabetes medication therapy adherence clinic. Pharm Pract (Granada). 2010;8(4):250-254.
39. Kocarnik BM, Liu CF, Wong ES et al. Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence? BMC Health Serv Res. 2012;12:391.
40. Rothman RL, Mulvaney S, Elsay TA et al. Self-management behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes. Pediatrics. 2008;121(4):e912-e919.
41. Raum E, Kramer HU, Ruter G et al. Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012;97(3):377-384.
42. Jamous RM, Sweileh WM, Abu-Taha AS, Sawalha AF, Zyoud SH, Morisky DE. Adherence and satisfaction with oral hypoglycemic medications: a pilot study in Palestine. Int J Clin Pharm. 2011;33(6):942-948.
43. Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167(17):1853-1860.
44. Ngo-Metzger Q, Sorkin DH, Billimek J, Greenfield S, Kaplan SH. The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes. J Gen Intern Med. 2012;27(4):432-437.
45. Parada H Jr., Horton LA, Cherrington A, Ibarra L, Ayala GX. Correlates of medication nonadherence among Latinos with type 2 diabetes. Diabetes Educ. 2012;38(4):552-561.
46. Martinez YV, Prado-Aguilar CA, Rascon-Pacheco RA, Valdivia-Martinez JJ. Quality of life associated with treatment adherence in patients with type 2 diabetes: a cross sectional study. BMC Health Serv Res. 2008;8:164.
47. Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. N Am J Med Sci. 2011;3(9):418-423.
48. Mackey K, Parchman ML, Leykum LK, Lanham HJ, Noel PH, Zeber JE. Impact of the Chronic Care Model on medication adherence when patients perceive cost as a barrier. Prim Care Diabetes. 2012;6(2):137-142.
49. Bailey GR, Barner JC, Weems JK et al. Assessing barriers to medication adherence in underserved patients with diabetes in Texas. Diabetes Educ. 2012;38(2):271-279.
50. Brod M, Rana A, Barnett AH. Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses. Curr Med Res Opin. 2012;28(12):1933-1946.
51. Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med. 2012;29(5):682-689.
52. de Vries ST, Keers JC, Visser R et al. Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes. J Psychosom Res. 2014;76(2):134-138.
53. Morello CM, Chynoweth M, Kim H, Singh RF, Hirsch JD. Strategies to improve medication adherence reported by diabetes patients and caregivers: results of a Taking Control of Your Diabetes Survey (February). Ann Pharmacother. 2011;45(2):145-153.
54. Florez H, Luo J, Castillo-Florez S et al. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes. Postgrad Med. 2010;122(2):112-120.
55. White AJ, Kellar I, Prevost AT et al. Adherence to hypoglycaemic medication among people with type 2 diabetes in primary care. Prim Care Diabetes. 2012;6(1):27-33.
56. Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34(4):692-697.
57. Aikens JE, Piette JD. Longitudinal association between medication adherence and glycaemic control in type 2 diabetes. Diabet Med. 2013;30(3):338-344.
58. Pascal IG, Ofoedu JN, Uchenna NP, Nkwa AA, Uchamma GU. Blood glucose control and medication adherence among adult type 2 diabetic Nigerians attending a primary care clinic in under-resourced environment of eastern Nigeria. N Am J Med Sci. 2012;4(7):310-315.
59. Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Adherence to glyburide and metformin and associated factors in type 2 diabetes in Isfahan, Iran. Iran J Pharm Res. 2011;10(4):933-939.
60. Al-Qazaz HKH, Sulaiman SA, Hassali MA et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011;33(6):1028-1035.
61. Alvarez Guisasola F, Tofe Povedano S, Krishnarajah G, Lyu R, Mavros P, Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab. 2008;10(suppl 1):25-32.
62. Bell RA, Andrews JS, Arcury TA, Snively BM, Golden SL, Quandt SA. Depressive symptoms and diabetes self-management among rural older adults. Am J Health Behav. 2010;34(1):36-44.
63. Kurlander JE, Kerr EA, Krein S, Heisler M, Piette JD. Cost-related nonadherence to medications among patients with diabetes and chronic pain: factors beyond finances. Diabetes Care. 2009;32(12):2143-2148.
64. Katon W, Russo J, Lin EH et al. Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med. 2009;71(9):965-972.
65. Aikens JE. Prospective associations between emotional distress and poor outcomes in type 2 diabetes. Diabetes Care. 2012;35(12):2472-2478.
66. Osborn CY, Egede LE. The relationship between depressive symptoms and medication nonadherence in type 2 diabetes: the role of social support. Gen Hosp Psychiatry. 2012;34(3):249-253.
67. Kreyenbuhl J, Leith J, Medoff DR et al. A comparison of adherence to hypoglycemic medications between type 2 diabetes patients with and without serious mental illness. Psychiatry Res. 2011;188(1):109-114.
68. Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med. 2009;32(3):278-284.
69. Aflakseir A. Role of illness and medication perceptions on adherence to medication in a group of Iranian patients with type 2 diabetes. J Diabetes. 2012;4(3):243-247.
70. Sweileh WM, Zyoud SH, Abu Nab'a RJ et al. Influence of patients’ disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014;14:94.
71. Walker RJ, Smalls BL, Hernandez-Tejada MA, Campbell JA, Davis KS, Egede LE. Effect of diabetes fatalism on medication adherence and self-care behaviors in adults with diabetes. Gen Hosp Psychiatry. 2012;34(6):598-603.
72. Walker RJ, Smalls BL, Hernandez-Tejada MA, Campbell JA, Egede LE. Effect of diabetes self-efficacy on glycemic control, medication adherence, self-care behaviors, and quality of life in a predominantly low-income, minority population. Ethn Dis. 2014;24(3):349-355.
73. Smalls BL, Walker RJ, Hernandez-Tejada MA, Campbell JA, Davis KS, Egede LE. Associations between coping, diabetes knowledge, medication adherence and self-care behaviors in adults with type 2 diabetes. Gen Hosp Psychiatry. 2012;34(4):385-389.
74. Hernandez-Tejada MA, Campbell JA, Walker RJ, Smalls BL, Davis KS, Egede LE. Diabetes empowerment, medication adherence and self-care behaviors in adults with type 2 diabetes. Diabetes Technol Ther. 2012;14(7):630-634.
75. Schoenthaler AM, Schwartz BS, Wood C, Stewart WF. Patient and physician factors associated with adherence to diabetes medications. Diabetes Educ. 2012;38(3):397-408.
76. French DP, Wade AN, Farmer AJ. Predicting self-care behaviours of patients with type 2 diabetes: the importance of beliefs about behaviour, not just beliefs about illness. J Psychosom Res. 2013;74(4):327-333.
77. Lerman I, Diaz JP, Ibarguengoitia ME et al. Nonadherence to insulin therapy in low-income, type 2 diabetic patients. Endocr Pract. 2009;15(1):41-46.
78. Hong JS, Kang HC. Relationship between continuity of ambulatory care and medication adherence in adult patients with type 2 diabetes in Korea: a longitudinal analysis. Med Care. 2014;52(5):446-453.
79. Cheng JS, Tsai WC, Lin CL et al. Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: a decade experience of a universal health insurance program. Med Care. 2015;53(2):116-124.
80. Ratanawongsa N, Karter AJ, Parker MM et al. Communication and medication refill adherence: the Diabetes Study of Northern California. JAMA Intern Med. 2013;173(3):210-218.
81. Mayberry LS, Osborn CY. Family support, medication adherence, and glycemic control among adults with type 2 diabetes. Diabetes Care. 2012;35(6):1239-1245.
82. Borgsteede SD, Westerman MJ, Kok IL, Meeuse JC, de Vries TP, Hugtenburg JG. Factors related to high and low levels of drug adherence according to patients with type 2 diabetes. Int J Clin Pharm. 2011;33(5):779-787.
83. Kivimaki M, Batty GD, Hamer M et al. Influence of retirement on nonadherence to medication for hypertension and diabetes. CMAJ. 2013;185(17):E784-E790.
84. Tiv M, Viel JF, Mauny F et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French population-based study. PLoS One. 2012;7(3):e32412.
85. Vervloet M, Spreeuwenberg P, Bouvy ML, Heerdink ER, de Bakker DH, van Dijk L. Lazy Sunday afternoons: the negative impact of interruptions in patients’ daily routine on adherence to oral antidiabetic medication. A multilevel analysis of electronic monitoring data. Eur J Clin Pharmacol. 2013;69(8):1599-1606.
86. Vervloet M, van Dijk L, de Bakker DH et al. Short- and long-term effects of real-time medication monitoring with short message service (SMS) reminders for missed doses on the refill adherence of people with type 2 diabetes: evidence from a randomized controlled trial. Diabet Med. 2014;31(7):821-828.
87. Gonzalez JS, Schneider HE, Wexler DJ et al. Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care. 2013;36(4):831-837.
88. Egede LE, Gebregziabher M, Dismuke CE et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35(12):2533-2539.
89. Egede LE, Lynch CP, Gebregziabher M et al. Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes. J Gen Intern Med. 2013;28(2):208-215.
90. Walker EA, Shmukler C, Ullman R, Blanco E, Scollan-Koliopoulus M, Cohen HW. Results of a successful telephonic intervention to improve diabetes control in urban adults: a randomized trial. Diabetes Care. 2011;34(1):2-7.
91. Lawrence DB, Allison W, Chen JC, Demand M. Improving medication adherence with a targeted, technology-driven disease management intervention. Dis Manag. 2008;11(3):141-144.
92. Nesari M, Zakerimoghadam M, Rajab A, Bassampour S, Faghihzadeh S. Effect of telephone follow-up on adherence to a diabetes therapeutic regimen. Jpn J Nurs Sci. 2010;7(2):121-128.
93. Thiebaud P, Demand M, Wolf SA, Alipuria LL, Ye Q, Gutierrez PR. Impact of disease management on utilization and adherence with drugs and tests: the case of diabetes treatment in the Florida: a Healthy State (FAHS) program. Diabetes Care. 2008;31(9):1717-1722.
94. Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. Br J Clin Pharmacol. 2009;67(5):547-557.
95. Wolever RQ, Dreusicke M, Fikkan J et al. Integrative health coaching for patients with type 2 diabetes: a randomized clinical trial. Diabetes Educ. 2010;36:629-639.
96. Bogner HR, de Vries HF. Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial. Diabetes Educ. 2010;36(2):284-292.
97. Fall E, Roche B, Izaute M, Batisse M, Tauveron I, Chakroun N. A brief psychological intervention to improve adherence in type 2 diabetes. Diabetes Metab. 2013;39(5):432-438.
98. Gialamas A, Yelland LN, Ryan P et al. Does point-of-care testing lead to the same or better adherence to medication? A randomized controlled trial: the PoCT in General Practice Trial. Med J Aust. 2009;191(9):487-491.
99. van Bruggen R, Gorter K, Stolk RP, Zuithoff P, Klungel OH, Rutten GE. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice. Pharmacoepidemiol Drug Saf. 2009;18(11):983-991.
100. Mullan RJ, Montori VM, Shah ND et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med. 2009;169(17):1560-1568.
101. Odegard PS, Carpinito G, Christensen DB. Medication adherence program: adherence challenges and interventions in type 2 diabetes. J Am Pharm Assoc (2003). 2013;53(3):267-272.
102. Negarandeh R, Mahmoodi H, Noktehdan H, Heshmat R, Shakibazadeh E. Teach back and pictorial image educational strategies on knowledge about diabetes and medication/dietary adherence among low health literate patients with type 2 diabetes. Prim Care Diabetes. 2013;7(2):111-118.
103. Vervloet M, van Dijk L, Santen-Reestman J et al. SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored. Int J Med Inform. 2012;81(9):594-604.